Nagla Abdel Karim, Director of the Phase I Program at Inova Schar Cancer Institute, shared on X:
“It is such a great honor to be selected to chair the oligometastatic subgroup.”
Source: Nagla Abdel Karim/X
Photo of Nagla Abdel Karim from netrf.org
